📰 Current Prescribing News
Page 2 - Current Prescribing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Current Prescribing. Real-time updates on events, politics, business and more.
April 29, 2023
Teva and MedinCell Announce FDA Approval of UZEDY™ Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of... | April 29, 2023
April 28, 2023
This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a Phase 3 clinical trial, UZEDY demonstrated
March 2, 2022
XARACOLL 300mg Dose Cohort Experienced Less Pain and XARACOLL was Generally Well Tolerated with an Adverse Event Profile Comparable to the Current Prescribing Information Innocoll Pharmaceuticals